Diseases, Conditions, Syndromes

COVID-19 pandemic responsible for decrease in hepatitis C testing

New research from Boston Medical Center finds that the COVID-19 emergency systemic changes made to decrease in-person visits during the pandemic have led to a decrease in hospital-wide Hepatitis C (HCV) testing by 50 percent, ...

Medical research

Opt-out universal hep C screening in emergency dept is useful

Emergency department opt-out universal hepatitis C virus (HCV) screening can identify a large number of unrecognized HCV infections, including among those born after 1965, according to research published in the May 15 issue ...

HIV & AIDS

Bundled rapid HIV/Hep C testing may improve infection awareness

(HealthDay)—For people with substance use disorders, combining HIV and hepatitis C virus (HCV) testing and providing immediate test results may increase the number of people who are aware of their infection status, according ...

Diseases, Conditions, Syndromes

Improvements needed for hepatitis C testing in youth

A new study led by Boston Medical Center uncovered a need to improve testing rates for Hepatitis C Virus (HCV) in young people, specifically those with documented substance use history. In the national data sample, under ...

Diseases, Conditions, Syndromes

Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...

Diseases, Conditions, Syndromes

FDA approves mavyret for children, adolescents with hep C

(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.

page 1 from 5